ArticleMolecular therapy. Methods & clinical development2023

Development of an AAV-CRISPR-Cas9-based treatment for dominant cone-rod dystrophy 6.

Russell W Mellen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.